K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · CENCORA INC.
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-20 | COR | CENCORA INC. | CENCORA, INC. | $1.1M | Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under CMS FY 2026 Medicare's Part B physician fee schedule. Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R.4299) Reimbursement policies impacting drug shortages Part B drug pricing changes Preventing and Mitigating Generic Drug Shortages CMS FY 2026 Medicares Part B Physician Fee Schedule: Proposed Changes to Bonafide Service Fees Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) Support for Fair Pharmacy Reimbursement Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile |
| 2026-04-20 | COR | CENCORA INC. | THE DUBERSTEIN GROUP INC. | $75K | Issues related to trade Issues related to health care and pharmaceutical industry |
| 2026-04-20 | COR | CENCORA INC. | HARBINGER STRATEGIES, LLC | $60K | Issues related to Healthcare Reform. The One Big Beautiful Bill Act (H.R.1): issues related to the tax treatment of the LIFO inventory valuation method and business tax issues. The FY2027 National Defense Authorization Act (No Bill Number): issues related to DoDs supply of essential and lifesaving medicines. |
| 2026-04-19 | COR | CENCORA INC. | INLET STRATEGIES | $30K | Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands Issues related to the federal taxation of income earned in Puerto Rico Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory |
| 2026-04-15 | COR | CENCORA INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60K | IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS). Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement. |
| 2026-01-20 | COR | CENCORA INC. | CENCORA, INC. | $1.9M | Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R.4299) Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages CMS Proposed Medicare Physician Fee Schedule Rule Proposed Changes to Bonafide Service Fees Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) Strategic National Stockpile Essential Medicines Strategic Stockpile Department o |
| 2026-01-20 | COR | CENCORA INC. | HARBINGER STRATEGIES, LLC | $60K | Issues related to Healthcare Reform. The One Big Beautiful Bill Act (H.R.1): issues related to the tax treatment of the LIFO inventory valuation method and business tax issues. The FY2026 National Defense Authorization Act (H.R.3838/S.2296): issues related to DoDs supply of essential and lifesaving medicines. |
| 2026-01-19 | COR | CENCORA INC. | THE DUBERSTEIN GROUP INC. | $75K | Issues related to trade Introductions & issues related to supply chains Issues related to health care and pharmaceutical industry |
| 2026-01-18 | COR | CENCORA INC. | INLET STRATEGIES | $30K | Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands Issues related to the federal taxation of income earned in Puerto Rico |
| 2026-01-15 | COR | CENCORA INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60K | IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS). Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement. |
| 2025-10-20 | COR | CENCORA INC. | CENCORA, INC. | $680K | One Big Beautiful Bill Act/Budget Reconciliation (H.R.1) Tariff proposed policies LIFO accounting method Global Intangible Low-taxed Income (GILTI) Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). CMS Proposed Medicare Physician Fee Schedule Rule Protecting Patient Access to Cancer and Complex Therapies Act 2025 Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduct |
| 2025-10-20 | COR | CENCORA INC. | THE DUBERSTEIN GROUP INC. | $75K | Issues related to trade Issues related to health care and pharmaceutical industry |
| 2025-10-20 | COR | CENCORA INC. | HARBINGER STRATEGIES, LLC | $60K | Issues related to Healthcare Reform. The One Big Beautiful Bill Act (H.R.1): issues related to the tax treatment of the LIFO inventory valuation method and business tax issues. The FY2026 National Defense Authorization Act (H.R.3838/S.2296): issues related to DoDs supply of essential and lifesaving medicines. |
| 2025-10-16 | COR | CENCORA INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60K | IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS). Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement. |
| 2025-10-13 | COR | CENCORA INC. | INLET STRATEGIES | $30K | Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands |
| 2025-07-21 | COR | CENCORA INC. | CENCORA, INC. | $760K | Ensuring Community Access to Pharmacist Services Act (H.R. 3164) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Protecting Patient Access to Cancer and Complex Therapies Act 2025 Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164) Impacts to pharmacy Part D drug pricing in IRA Strategic National Stockpile. Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). SUPPORT Act Reauthorization Medical Supply Resiliency |
| 2025-07-21 | COR | CENCORA INC. | THE DUBERSTEIN GROUP INC. | $75K | Issues related to trade |
| 2025-07-21 | COR | CENCORA INC. | HARBINGER STRATEGIES, LLC | $60K | Issues related to Healthcare Reform. The One Big Beautiful Bill Act (H.R.1): issues related to the tax treatment of the LIFO inventory valuation method and business tax issues. The FY2026 National Defense Authorization Act (H.R.3838/S.2296): issues related to DoDs supply of essential and lifesaving medicines. |
| 2025-07-16 | COR | CENCORA INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60K | IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS). Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement. |
| 2025-07-14 | COR | CENCORA INC. | INLET STRATEGIES | $30K | Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory HR 1: The One Big Beautiful Bill Act Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands |
| 2025-05-22 | COR | CENCORA INC. | THE DUBERSTEIN GROUP INC. | $0 | Issues related to Healthcare Reform; Issues related to Tax Reform Issues related to Healthcare Reform; Issues related to Tax Reform Issues related to Healthcare Reform; Issues related to Tax Reform Issues related to Healthcare Reform; Issues related to Tax Reform |
| 2025-04-21 | COR | CENCORA INC. | CENCORA, INC. | $450K | The Equitable Community Access to Pharmacist Services Act Inflation Reduction Act Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act Seniors Access to Critical Medicines Act (H.R. 2484) Protecting Patient Access to Cancer and Complex Therapies Act Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages Pharmacy and Medically Underserved Area Enhancement Act Preventing and Mitigating Generic Drug Shortages The Equitable Community Access to Pharmacist Services Act Seniors Access to Critical Medications Act (H.R. 2484) Strategic National Stockpile. Essential Medicines Strategic Stockpile Act Prescription Information Modernization Act Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response A |
| 2025-04-21 | COR | CENCORA INC. | HARBINGER STRATEGIES, LLC | $60K | Issues related to Healthcare Reform. Tax reconciliation legislation (No Bill Number): issues related to the tax treatment of the LIFO inventory valuation method. General monitoring of business tax issues. The FY2026 National Defense Authorization Act (No Bill Number): issues related to DoDs supply of essential and lifesaving medicines. |
| 2025-04-18 | COR | CENCORA INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60K | IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS). Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement. |
| 2025-04-14 | COR | CENCORA INC. | INLET STRATEGIES | $30K | Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory |
| 2025-01-21 | COR | CENCORA INC. | CENCORA, INC. | $1.1M | Proposed modifications to the existing definition of distributor bona fide service fees The Equitable Community Access to Pharmacist Services Act (H.R. 1770/ S.2477) Inflation Reduction Act Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act (S.1491). Seniors Access to Critical Medicines Act (H.R. 5526/S.3458). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages Senate Finance Draft Medicare Drug Shortage Prevention Policies Pharmacy and Medically Underserved Area Enhancement Act (S.1491). Preventing and Mitigating Generic Drug Shortages The Equitable Community Access to Pharmacist Services Act (H.R. 1770/S.2477). Seniors Access to Critical |
| 2025-01-21 | COR | CENCORA INC. | HARBINGER STRATEGIES, LLC | $60K | Issues related to Healthcare Reform. General monitoring of business tax issues. The FY2025 National Defense Authorization Act (H.R. 8070): issues related to DoDs supply of essential and lifesaving medicines. |